RLBBX
Price
$34.70
Change
+$0.21 (+0.61%)
Updated
Jan 17 closing price
Net Assets
240.18B
VTARX
Price
$10.60
Change
+$0.02 (+0.19%)
Updated
Jan 17 closing price
Net Assets
640.87M
Ad is loading...

RLBBX vs VTARX

Header iconRLBBX vs VTARX Comparison
Open Charts RLBBX vs VTARXBanner chart's image
American Funds American Balanced R2
Price$34.70
Change+$0.21 (+0.61%)
VolumeN/A
Net Assets240.18B
Virtus Tactical Allocation R6
Price$10.60
Change+$0.02 (+0.19%)
VolumeN/A
Net Assets640.87M
RLBBX vs VTARX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBBX vs. VTARX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBBX is a Buy and VTARX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBBX has more cash in the bank: 240B vs. VTARX (641M). VTARX pays higher dividends than RLBBX: VTARX (1.70) vs RLBBX (1.58). RLBBX was incepted earlier than VTARX: RLBBX (23 years) vs VTARX (4 years). RLBBX is a more actively managed with annual turnover of: 171.00 vs. VTARX (23.00). RLBBX has a lower initial minimum investment than VTARX: RLBBX (250) vs VTARX (2500000). RLBBX annual gain was more profitable for investors over the last year : 11.43 vs. VTARX (4.35).
RLBBXVTARXRLBBX / VTARX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years4 years-
Gain YTD1.9090.952200%
Front LoadN/AN/A-
Min. Initial Investment25025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets240B641M37,441%
Annual Yield % from dividends1.581.7093%
Returns for 1 year11.434.35263%
Returns for 3 years10.54-7.45-141%
Returns for 5 years25.81N/A-
Returns for 10 years49.88N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HUN17.870.46
+2.64%
Huntsman Corp
PUBM14.520.11
+0.76%
PubMatic
SATL2.900.02
+0.69%
Satellogic
ACGL95.51-0.59
-0.61%
Arch Capital Group Ltd
LEXX1.90-0.08
-3.80%
Lexaria Bioscience Corp